ZNF567

gene
On this page

Also known as MGC45586

Summary

ZNF567 (zinc finger protein 567, HGNC:28696) is a protein-coding gene on chromosome 19q13.12, encoding Zinc finger protein 567 (Q8N184). May be involved in transcriptional regulation.

Predicted to enable DNA-binding transcription factor activity and RNA polymerase II cis-regulatory region sequence-specific DNA binding activity. Predicted to be involved in regulation of transcription by RNA polymerase II. Predicted to be located in nucleus.

Source: NCBI Gene 163081 — RefSeq curated summary.

At a glance

  • Clinical variants (ClinVar): 53 total
  • MANE Select transcript: NM_001322917

Identifiers

Gene identifiers

FieldValue
HGNC IDHGNC:28696
Approved symbolZNF567
Namezinc finger protein 567
Location19q13.12
Locus typegene with protein product
StatusApproved
AliasesMGC45586
Ensembl geneENSG00000189042
Ensembl biotypeprotein_coding
Entrez163081

Gene structure

Transcript identifiers

Ensembl transcripts: 30 — 28 protein_coding, 1 retained_intron, 1 nonsense_mediated_decay

ENST00000360729, ENST00000536254, ENST00000585696, ENST00000588311, ENST00000589264, ENST00000590392, ENST00000591308, ENST00000682579, ENST00000910217, ENST00000910218, ENST00000910219, ENST00000910220, ENST00000910221, ENST00000910223, ENST00000910225, ENST00000910227, ENST00000915754, ENST00000915755, ENST00000915756, ENST00000915757, ENST00000915758, ENST00000915759, ENST00000915760, ENST00000915761, ENST00000915762, ENST00000941119, ENST00000941120, ENST00000941121, ENST00000941122, ENST00000941123

RefSeq mRNA: 28 — MANE Select: NM_001322917 NM_001300979, NM_001322911, NM_001322912, NM_001322913, NM_001322914, NM_001322915, NM_001322916, NM_001322917, NM_001322918, NM_001322919, NM_001322920, NM_001363651, NM_001387759, NM_001387760, NM_001387761, NM_001387762, NM_001387763, NM_001387764, NM_001387765, NM_001387766, NM_001387767, NM_001387768, NM_001387769, NM_001387770, NM_001387771, NM_001387772, NM_001387773, NM_152603

CCDS: CCDS12495, CCDS74349, CCDS86756

Canonical transcript exons

ENST00000682579 — 6 exons

ExonStartEnd
ENSE000012583763671278136712867
ENSE000029376803668761236687634
ENSE000035784903669480236694876
ENSE000036687073671238636712512
ENSE000039161643671894836721336
ENSE000039183113668939736689497

Expression profiles

Bgee: expression breadth ubiquitous, 245 present calls, max score 91.07.

FANTOM5 (CAGE): breadth ubiquitous, TPM avg 2.2309 / max 65.0649, expressed in 1104 samples.

FANTOM5 promoters (1 alternative TSS)

Promoter IDTPM avgSamples expressed
1755232.23091104

Top tissues by expression

250 total, by Bgee expression score (0-100, higher = more expressed):

TissueAnatomy IDExpression scoreQuality
endothelial cellCL:000011591.07gold quality
epithelial cell of pancreasCL:000008389.56gold quality
primordial germ cell in gonadCL:0000670 ∩ UBERON:000099188.20gold quality
male germ line stem cell (sensu Vertebrata) in testisCL:0000089 ∩ UBERON:000047383.35gold quality
calcaneal tendonUBERON:000370183.21gold quality
germinal epithelium of ovaryUBERON:000130481.83gold quality
ventricular zoneUBERON:000305379.63gold quality
cortical plateUBERON:000534379.39gold quality
buccal mucosa cellCL:000233679.27gold quality
placentaUBERON:000198779.25gold quality
thymusUBERON:000237079.25gold quality
palpebral conjunctivaUBERON:000181278.78gold quality
ganglionic eminenceUBERON:000402378.51gold quality
left testisUBERON:000453378.51gold quality
cartilage tissueUBERON:000241878.44gold quality
right testisUBERON:000453478.31gold quality
testisUBERON:000047378.23gold quality
islet of LangerhansUBERON:000000678.02gold quality
lymph nodeUBERON:000002977.86gold quality
spermCL:000001977.45gold quality
Brodmann (1909) area 23UBERON:001355477.32gold quality
skin of hipUBERON:000155477.22gold quality
smooth muscle tissueUBERON:000113577.18gold quality
stromal cell of endometriumCL:000225576.63gold quality
adrenal tissueUBERON:001830376.41gold quality
right adrenal gland cortexUBERON:003582776.35gold quality
cerebellar cortexUBERON:000212976.13gold quality
cerebellar hemisphereUBERON:000224576.12gold quality
pigmented layer of retinaUBERON:000178275.95gold quality
sural nerveUBERON:001548875.89gold quality

Single-cell (SCXA)

Detected in 1 experiment(s), a significant marker in 0.

ExperimentMarker?Max mean expression
E-ANND-3no4.72

Regulation

Is transcription factor: no

Upstream regulators (CollecTRI, top): STAT1

miRNA regulators (miRDB)

48 targeting ZNF567, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):

miRNAMax scoreAvg scoremiRNA target_count
HSA-MIR-4795-3P100.0074.624024
HSA-MIR-3163100.0077.238605
HSA-MIR-1277-5P100.0073.955056
HSA-MIR-190A-3P100.0080.355520
HSA-MIR-186-5P99.9970.833707
HSA-MIR-428299.9975.366408
HSA-MIR-548AW99.9972.573559
HSA-MIR-366299.9973.825684
HSA-MIR-433-3P99.9869.371203
HSA-MIR-1468-3P99.9672.743797
HSA-MIR-539-5P99.9370.302855
HSA-MIR-4760-3P99.9370.502385
HSA-MIR-6809-3P99.9171.453814
HSA-MIR-454-3P99.9174.011925
HSA-MIR-130A-3P99.9073.311861
HSA-MIR-130B-3P99.9073.271850
HSA-MIR-301A-3P99.9073.151839
HSA-MIR-301B-3P99.9073.191836
HSA-MIR-366699.9073.241833
HSA-MIR-429599.9073.111838
HSA-LET-7A-2-3P99.8770.531921
HSA-MIR-394199.8670.542735
HSA-LET-7G-3P99.8570.431929
HSA-MIR-94499.8270.853042
HSA-MIR-4694-3P99.7969.532640
HSA-MIR-556-3P99.7468.751203
HSA-MIR-46699.6770.852863
HSA-MIR-3120-3P99.5470.282669
HSA-MIR-467299.5071.582893
HSA-MIR-469699.4867.481040

Cross-species orthologs

2 orthologs

OrganismSymbolGene ID
drosophila_melanogasterCG14442FBGN0029893
drosophila_melanogasterCG14440FBGN0029894

Paralogs (11): IKZF2 (ENSG00000030419), ZNF821 (ENSG00000102984), ZNF639 (ENSG00000121864), IKZF4 (ENSG00000123411), ZNF382 (ENSG00000161298), IKZF3 (ENSG00000161405), ZNF613 (ENSG00000176024), IKZF1 (ENSG00000185811), ZNF649 (ENSG00000198093), ZNF564 (ENSG00000249709), ZNF350 (ENSG00000256683)

Protein

Protein identifiers

Zinc finger protein 567Q8N184 (reviewed: Q8N184)

All UniProt accessions (4): F8WEL6, Q8N184, K7EMD5, K7ESK1

UniProt curated annotations — full annotation on UniProt →

Function. May be involved in transcriptional regulation.

Subcellular location. Nucleus.

Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.

Isoforms (3)

UniProt IDNamesCanonical?
Q8N184-33yes
Q8N184-11
Q8N184-22

RefSeq proteins (28): NP_001287908, NP_001309840, NP_001309841, NP_001309842, NP_001309843, NP_001309844, NP_001309845, NP_001309846, NP_001309847, NP_001309848, NP_001309849, NP_001350580, NP_001374688, NP_001374689, NP_001374690, NP_001374691, NP_001374692, NP_001374693, NP_001374694, NP_001374695, NP_001374696, NP_001374697, NP_001374698, NP_001374699, NP_001374700, NP_001374701, NP_001374702, NP_689816 (=MANE)

Domains & families (InterPro)

IDNameType
IPR001909KRABDomain
IPR013087Znf_C2H2_typeDomain
IPR036051KRAB_dom_sfHomologous_superfamily
IPR036236Znf_C2H2_sfHomologous_superfamily

Pfam: PF00096, PF01352

UniProt features (25 total): zinc finger region 15, cross-link 5, splice variant 2, chain 1, domain 1, sequence conflict 1

Structure

Experimental structures (PDB)

0 structures.

Predicted structure (AlphaFold)

ModelpLDDTFraction very-high
AF-Q8N184-F170.850.29

Functional residue map

Curated UniProt residues grouped by drug-discovery relevance — catalytic, ligand-binding, modification, and mutation-validated positions. Source: UniProtKB sequence features.

Post-translational modifications (5): 173, 202, 217, 233, 447

Function

Pathways and Gene Ontology

Reactome pathways

1 pathways

IDPathway
R-HSA-212436Generic Transcription Pathway

MSigDB gene sets: 54 (showing top): RODRIGUES_THYROID_CARCINOMA_ANAPLASTIC_UP, DODD_NASOPHARYNGEAL_CARCINOMA_UP, MOREAUX_MULTIPLE_MYELOMA_BY_TACI_DN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, SENGUPTA_NASOPHARYNGEAL_CARCINOMA_WITH_LMP1_UP, JOHNSTONE_PARVB_TARGETS_3_DN, GOMF_TRANSCRIPTION_REGULATOR_ACTIVITY, CSHL1_TARGET_GENES, SALL4_TARGET_GENES, ZNF26_TARGET_GENES, ZNF486_TARGET_GENES, MIR4795_3P, MIR6809_3P, MIR539_5P, MIR548L

GO Biological Process (4): regulation of transcription by RNA polymerase II (GO:0006357), regulation of DNA-templated transcription (GO:0006355), regulation of macromolecule metabolic process (GO:0060255), regulation of primary metabolic process (GO:0080090)

GO Molecular Function (6): RNA polymerase II cis-regulatory region sequence-specific DNA binding (GO:0000978), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), DNA binding (GO:0003677), protein binding (GO:0005515), metal ion binding (GO:0046872)

GO Cellular Component (1): nucleus (GO:0005634)

Reactome top-level categories

Rollup of top-1 pathways:

CategoryPathways
RNA Polymerase II Transcription1

GO top-level categories

Rollup of top GO terms by namespace:

CategoryTerms
regulation of DNA-templated transcription2
regulation of metabolic process2
transcription by RNA polymerase II1
DNA-templated transcription1
regulation of gene expression1
regulation of RNA biosynthetic process1
macromolecule metabolic process1
primary metabolic process1
RNA polymerase II transcription regulatory region sequence-specific DNA binding1
cis-regulatory region sequence-specific DNA binding1
transcription cis-regulatory region binding1
transcription regulator activity1
transition metal ion binding1
nucleic acid binding1
binding1
cation binding1
intracellular membrane-bounded organelle1

Protein interactions and networks

STRING

472 interactions, top by confidence (×1000):

Protein AProtein BPartner UniProtScore
ZNF567N4BP2Q86UW6543
ZNF567SYCE1LA8MT33490
ZNF567ZWILCHQ9H900486
ZNF567ETFBP38117472
ZNF567URB2Q14146430
ZNF567SPEF1Q9Y4P9430
ZNF567PRDX6P30041427
ZNF567DENND2CQ68D51419
ZNF567OSBPL7Q9BZF2397
ZNF567TMEM131LA2VDJ0394
ZNF567CTTNBP2NLQ9P2B4375
ZNF567RNF144AP50876375
ZNF567FCSKQ8N0W3368
ZNF567LNPKQ9C0E8367
ZNF567DHX35Q9H5Z1364

IntAct

19 interactions, top by confidence:

ABTypeScore
MAP3K20ZNF567psi-mi:“MI:0915”(physical association)0.780
ZNF567MAP3K20psi-mi:“MI:0915”(physical association)0.780
ZNF567MAP3K20psi-mi:“MI:0915”(physical association)0.670
MAP3K20ZNF567psi-mi:“MI:0915”(physical association)0.670
FAM9BZNF567psi-mi:“MI:0915”(physical association)0.560
TRIM28ZNF316psi-mi:“MI:0914”(association)0.530
ZNF567HSPD1psi-mi:“MI:0915”(physical association)0.400
PCBD1ZNF567psi-mi:“MI:0915”(physical association)0.370
C9orf72CHD2psi-mi:“MI:0914”(association)0.350
ZNF567IPO8psi-mi:“MI:0914”(association)0.350
ZNF567MAP3K20psi-mi:“MI:0915”(physical association)0.000

BioGRID (17): ZNF567 (Two-hybrid), FAM9B (Two-hybrid), ZNF567 (Two-hybrid), ZAK (Two-hybrid), ZNF567 (Affinity Capture-RNA), ZNF567 (Two-hybrid), ZNF567 (Proximity Label-MS), ZNF567 (Proximity Label-MS), ZNF567 (Affinity Capture-RNA), ZNF567 (Affinity Capture-MS), ZNF567 (Affinity Capture-MS), ZNF567 (Proximity Label-MS), ZNF567 (Positive Genetic), ZNF567 (Affinity Capture-MS), ZNF567 (Affinity Capture-MS)

ESM2 similar proteins: A0A087WUV0, A0JNB1, A2VDP4, B2RUI1, P0CG31, P10072, P17025, P17036, P17097, P18733, P51814, Q08ER8, Q09FC8, Q0VGE8, Q14590, Q15937, Q16600, Q2M3X9, Q4V8A8, Q5CZA5, Q5R8G9, Q5RBX0, Q5VIY5, Q68DI1, Q6J6I6, Q6NX49, Q6P1L6, Q6PG37, Q6ZMS4, Q6ZMW2, Q80YP6, Q86UD4, Q86Y25, Q8IZ26, Q8N184, Q8NB42, Q8NEK5, Q8TAF7, Q8TF47, Q8WXB4

Diamond homologs: A0JPL0, A2VDP4, A6QLU5, A6QPT6, A8MQ14, A8MUZ8, A8MWA4, B1APH4, B2RXC5, E9PYI1, E9Q8G5, O75290, O94892, P08042, P0CH99, P0CI00, P17014, P17025, P17030, P17031, P17032, P17098, P21506, P51508, P51523, P51786, P51814, P52736, P52738, Q02525, Q03923, Q03936, Q06730, Q06732, Q0VCB0, Q13401, Q14587, Q16587, Q2M218, Q2M3X9

SIGNOR signaling

0 interactions.

Disease & clinical

Clinical variants and AI predictions

ClinVar

53 variants total. Per-class counts are floors (≥ shown; pagination cap):

ClassificationCount (floor)
Pathogenic0
Likely pathogenic0
Uncertain significance49
Likely benign2
Benign0

Top pathogenic / likely-pathogenic (0)

SpliceAI

1135 predictions. Top by Δscore:

VariantEffectΔscore
19:36712509:GTGG:Gdonor_gain1.0000
19:36712510:TGG:Tdonor_gain1.0000
19:36712511:GG:Gdonor_gain1.0000
19:36712511:GGG:Gdonor_gain1.0000
19:36712512:GG:Gdonor_gain1.0000
19:36712513:G:GCdonor_loss1.0000
19:36712513:G:GGdonor_gain1.0000
19:36712514:T:Gdonor_loss1.0000
19:36712773:C:Gacceptor_gain1.0000
19:36712777:TCA:Tacceptor_loss1.0000
19:36712778:CAG:Cacceptor_loss1.0000
19:36712779:A:AGacceptor_gain1.0000
19:36712779:AG:Aacceptor_gain1.0000
19:36712779:AGG:Aacceptor_gain1.0000
19:36712779:AGGG:Aacceptor_loss1.0000
19:36712779:AGGGT:Aacceptor_gain1.0000
19:36712780:G:Aacceptor_gain1.0000
19:36712780:G:GAacceptor_gain1.0000
19:36712780:GGG:Gacceptor_gain1.0000
19:36712780:GGGT:Gacceptor_gain1.0000
19:36712780:GGGTG:Gacceptor_gain1.0000
19:36712866:GG:Gdonor_gain1.0000
19:36712867:GG:Gdonor_gain1.0000
19:36687692:G:GTdonor_gain0.9900
19:36689496:GT:Gdonor_gain0.9900
19:36694796:CCTTA:Cacceptor_loss0.9900
19:36694797:CTTA:Cacceptor_loss0.9900
19:36694799:TA:Tacceptor_loss0.9900
19:36694800:A:ATacceptor_loss0.9900
19:36694801:G:Aacceptor_loss0.9900

AlphaMissense

0 scored. Top likely-pathogenic:

dbSNP variants (sampled 300 via entrez): RS1000058603 (19:36681365 G>A), RS1000097529 (19:36712308 A>G), RS1000145452 (19:36727757 T>C), RS1000257595 (19:36706191 A>G), RS1000302185 (19:36727541 G>A), RS1000341319 (19:36693259 T>C,G), RS1000369494 (19:36675042 T>A,G), RS1000439115 (19:36688806 C>A), RS1000444800 (19:36688546 G>A,T), RS1000515902 (19:36687122 A>C), RS1000547163 (19:36687405 A>C), RS1000632125 (19:36694798 T>C,G), RS1000682160 (19:36680287 A>C,T), RS1000736765 (19:36672568 C>T), RS1000776040 (19:36693803 A>C,G)

Disease associations

OMIM: gene `` | disease phenotypes:

GenCC curated gene-disease

Mondo (0):

Orphanet (0):

HPO phenotypes

0 total (0 of 0 shown, HPO-id order):

GWAS associations

0 associations (top):

Drugs & pharmacology

Drug and pharmacology data

Is drug target: no

PharmGKB: 1 entry (VIP=true, CPIC=false)

CTD chemical–gene interactions

31 total (human), top 30 by PubMed support.

ChemicalActions (top 5)PubMed papers
bisphenol Aaffects cotreatment, decreases methylation, increases expression2
trichostatin Aaffects cotreatment, decreases expression2
Tobacco Smoke Pollutionincreases expression2
Valproic Aciddecreases expression2
3-((6-(2-methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methane sulfonamidedecreases expression1
TAK-243increases sumoylation1
dicrotophosdecreases expression1
triphenyl phosphateaffects expression1
arseniteaffects binding, decreases reaction1
lei gong tengincreases expression1
epigallocatechin gallateincreases expression1
4-(5-benzo(1,3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamideaffects cotreatment, decreases expression1
dorsomorphinaffects cotreatment, decreases expression1
jinfukangdecreases expression1
Fulvestrantaffects cotreatment, decreases methylation1
Air Pollutantsdecreases expression, increases abundance1
Clorgylineincreases expression1
Coaldecreases expression, increases abundance1
Succimerincreases expression, affects cotreatment1
Dimethyl Sulfoxideincreases expression1
Estradiolaffects expression1
Ethyl Methanesulfonateincreases expression1
Formaldehydedecreases expression1
Hydrogen Peroxidedecreases expression1
Methyl Methanesulfonateincreases expression1
Oxazoloneincreases expression1
Smokedecreases expression, increases abundance1
Urethaneincreases expression1
Cyclosporineincreases expression1
Aflatoxin B1affects expression1

Clinical trials (associated diseases)

0 trials via MONDO — disease-level, not drug-specific.

No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.